Screening for prostate cancer: Recommendation and rationale
Screening for prostate cancer: Recommendation and rationale
复制标题
DOI：
10.7326/0003-4819-137-11-200212030-00013
复制
发表时间：
2002-12-03
影响因子：
39.2
通讯作者：
Woolf, SH
中科院分区：
文献类型：
--
作者：
Berg, AO;Allan, JD;Woolf, SH
本声明总结了目前美国预防服务工作组（USPSTF）关于前列腺癌筛查的建议，并更新了1996年关于该主题的建议。USPSTF关于这一主题的完整建议和基本原理声明，包括对支持证据的简要审查，可通过USPSTF网站（www.preventiveservices.ahrq.gov）、国家指南信息交换中心（www.guideline.gov）获得，并通过医疗保健研究和质量出版物信息交换中心（电话：800-358- 9295;电子邮件：ahrqpubs@ahrq.gov）获得。本声明所依据的完整信息，包括表格和参考文献，可在本期随附的文章以及已经提到的网站上的证据和系统证据综述摘要中获得。
This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations on screening for prostate cancer and updates the 1996 recommendations on this topic. The complete USPSTF recommendation and rationale statement on this topic, which includes a brief review of the supporting evidence, is available through the USPSTF Web site (www.preventiveservices.ahrq.gov), the National Guideline Clearinghouse (www.guideline.gov), and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (telephone, 800-358- 9295; e-mail, ahrqpubs@ahrq.gov). The complete information on which this statement is based, including tables and references, is available in the accompanying article in this issue and in the summary of the evidence and systematic evidence review on the Web sites already mentioned.